What Researchers Did
Researchers conducted a preliminary retrospective study to investigate the role of nitric oxide production in diabetic wound healing, particularly in relation to hyperbaric oxygen therapy and topical becaplermin.
What They Found
The study suggested that nitric oxide production is reduced in nonhealing diabetic wounds, and topical becaplermin therapy is effective only when this deficiency is corrected. Data also indicated that diabetic ulcer repair might not occur below a critical level of endogenous nitric oxide production, supporting combined becaplermin and hyperbaric oxygen therapy for chronic ulcers with nitric oxide deficiency and local hypoxia.
What This Means for Canadian Patients
Canadian patients with chronic diabetic ulcers that are not healing may benefit from therapies that address nitric oxide deficiency. Combining hyperbaric oxygen therapy with topical becaplermin could offer a more effective treatment approach for these challenging wounds.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a preliminary retrospective study, its findings are limited by its design and may not be broadly generalizable.